Skip to main content
E

Empatica

Empatica develops FDA-cleared wearable devices and a health monitoring platform that continuously collects clinical-quality health data and digital biomarkers from everyday life. This technology enables researchers and clinicians to monitor conditions such as epilepsy and movement disorders, enhancing data collection for clinical trials and real-world health insights.

Cambridge, United KingdomFounded 201111730K+ followers
Updated 20 months ago

Funding

$25.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Collecting continuous, clinical-quality health data for conditions like epilepsy and movement disorders often requires patients to visit clinics, limiting the amount of real-world data available to researchers and clinicians. Traditional methods can be disruptive to patients' lives and may not capture the full spectrum of their condition's impact on daily activities.

Solution

Empatica offers an FDA-cleared health monitoring platform that utilizes wearable devices and AI algorithms to continuously collect and analyze clinical-quality health data and digital biomarkers from patients in their everyday lives. The platform includes the EmbracePlus wearable, the Care software suite, and a Cloud API for clinical trials. This end-to-end remote monitoring solution is applicable across various therapeutic areas, enabling researchers and clinicians to monitor conditions such as epilepsy and movement disorders, enhancing data collection for clinical trials and real-world health insights. The platform provides a range of digital measures, facilitating the development of novel digital biomarkers that can be used as digital endpoints.

Target Audience

The primary users are researchers, clinicians, and pharmaceutical companies focused on clinical trials, remote patient monitoring, and the development of digital biomarkers for neurological and other conditions.

Features

  • FDA-cleared wearable devices for continuous, real-world data collection
  • Care software suite for data visualization and analysis
  • Cloud API for seamless data integration into clinical trials
  • Digital biomarker development for various therapeutic areas
  • Remote patient monitoring capabilities
  • Actigraphy to measure sleep and physical activity
  • Algorithms for epilepsy monitoring
This profile is AI-generated and may contain inaccuracies.